GO:1901208 negative regulation of heart looping: Cardiac Looping Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901208 (negative regulation of heart looping) describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of heart looping, a critical step in embryonic heart development.
• Heart looping is the asymmetric bending and rotation of the primitive heart tube that establishes left-right organ asymmetry; its negative regulation ensures proper chamber positioning and function.
• Key molecular players include the transcription factor Pitx2, which shows differential isoform expression and functional roles in heart looping regulation.
• Environmental teratogens such as isoniazid can disrupt heart looping by inducing oxidative stress, highlighting the sensitivity of this process to chemical exposure.
• Transcription factors like Sox18 are mechanistically implicated in heart development, providing candidate regulators of looping.
• Research on negative regulation of heart looping employs zebrafish, chick, and mouse models, combined with CRISPR knockout, knock-in, and overexpression strategies to dissect gene function [2,5].
Description
Heart looping is a fundamental morphogenetic event during embryogenesis in which the straight heart tube bends and rotates to establish the correct left-right asymmetry of the future chambers and outflow tract. Disruption of this process leads to congenital heart defects, underscoring the need to understand both the drivers and the brakes of looping. The Gene Ontology term GO:1901208, negative regulation of heart looping, captures any process that stops, prevents, or reduces the frequency, rate, or extent of heart looping. This term is essential for annotating gene functions that restrain or fine-tune looping, ensuring that the heart adopts its proper three-dimensional configuration. Research into negative regulation of heart looping has revealed roles for transcription factors such as Pitx2, which exhibits differential isoform expression and functional specificity in the chick embryo. Additionally, environmental factors like isoniazid can cause heart looping disorders in zebrafish by inducing oxidative stress, demonstrating that negative regulation can be triggered by external insults. Understanding these regulatory mechanisms is critical for uncovering the etiology of congenital heart diseases and for developing targeted interventions.
negative regulation of heart looping At A Glance
| GO ID | GO:1901208 |
|---|---|
| GO term | negative regulation of heart looping |
| Ontology | biological_process |
| Synonym | down regulation of cardiac looping; down-regulation of cardiac looping; downregulation of cardiac looping; down regulation of heart looping; down-regulation of heart looping; downregulation of heart looping; inhibition of cardiac looping; inhibition of heart looping; negative regulation of cardiac looping |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of heart looping during embryonic development. |
| Related process | Heart looping (GO:0001947) and regulation of heart looping (GO:1901207). |
| Taxonomic range | Metazoa, particularly vertebrates such as zebrafish, chick, and mouse. |
| Research relevance | Implicated in congenital heart defects and left-right asymmetry disorders. |
What Is GO:1901208?
According to the Gene Ontology, GO:1901208 (negative regulation of heart looping) is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of heart looping. Heart looping itself is the asymmetric bending and rotation of the embryonic heart tube that establishes left-right asymmetry. Thus, negative regulation of heart looping encompasses molecular and cellular events that inhibit, delay, or otherwise downregulate this morphogenetic movement, ensuring proper cardiac development.
Why Is negative regulation of heart looping Important in Cell Biology?
Negative regulation of heart looping is crucial for normal cardiac development because it ensures that the heart tube does not over-rotate or adopt incorrect left-right asymmetry, which would lead to malformations. Perturbations in this regulatory process can result in congenital heart defects, as evidenced by studies showing that teratogens like isoniazid disrupt heart looping in zebrafish through oxidative stress. Moreover, transcription factors such as Pitx2 are known to modulate looping, and their misregulation can affect cardiac situs and chamber formation. Thus, understanding the negative regulation of heart looping provides insights into the molecular etiology of congenital heart diseases and identifies potential therapeutic targets.
• Prevents excessive or aberrant heart looping that could lead to congenital heart defects.
• Maintains left-right asymmetry of the heart, which is essential for proper chamber alignment and function.
• Provides a mechanism for environmental factors (e.g., isoniazid) to disrupt heart development via oxidative stress.
• Involves transcription factors like Pitx2 that are critical for asymmetric organogenesis.
• Serves as a model for studying morphogenetic regulation in vertebrates.
• Helps explain the etiology of situs inversus and other laterality disorders.
• Guides tissue engineering approaches for generating functional cardiac organoids.
• Offers targets for screening teratogenic compounds that affect heart looping.
• Enables comparative studies of heart development across species (zebrafish, chick, mouse) [2,5].
• Facilitates the development of CRISPR-based models to dissect gene function in cardiac looping.
What Happens During negative regulation of heart looping?
Initiation of negative regulatory signals
In simple terms: The process begins when specific molecules signal the heart tube to slow down or stop its looping.
Negative regulation of heart looping is initiated by molecular cues that counteract the pro-looping signals. These cues can be intrinsic, such as transcription factors, or extrinsic, such as environmental stressors. For example, oxidative stress induced by isoniazid can trigger negative regulation, leading to heart looping disorders in zebrafish embryos. Similarly, differential expression of Pitx2 isoforms in the chick embryo suggests that specific isoforms may act as negative regulators of looping.
Transcription factor-mediated repression
In simple terms: Certain proteins that control gene expression can directly inhibit the genes that drive heart looping.
Transcription factors such as Pitx2 play a key role in repressing genes involved in heart looping. In the chick, Pitx2 isoforms exhibit differential expression and functional analysis indicates that they regulate heart looping, with some isoforms potentially acting as negative regulators. Additionally, Sox18, a transcription factor, has been mechanistically implicated in heart development, suggesting it may contribute to the negative regulation of looping.
Oxidative stress and cellular damage
In simple terms: Harmful molecules called reactive oxygen species can damage heart cells and disrupt looping.
Oxidative stress is a potent negative regulator of heart looping. Isoniazid exposure in zebrafish embryos induces oxidative stress, which leads to heart looping disorders. This suggests that reactive oxygen species can interfere with the cellular machinery required for looping, possibly by damaging proteins or DNA, or by altering signaling pathways.
Modulation of left-right asymmetry
In simple terms: The process ensures that the heart loops to the correct side and does not over-rotate.
Negative regulation of heart looping is essential for maintaining left-right asymmetry. Pitx2 is a key determinant of left-right asymmetry, and its differential isoform expression in the chick regulates heart looping direction and extent. Disruption of this regulation can lead to situs inversus or other laterality defects.
Integration with developmental timing
In simple terms: The negative regulation must occur at the right time to properly shape the heart.
The timing of negative regulation is critical. If it occurs too early or too late, heart looping may be incomplete or excessive. Studies in zebrafish show that isoniazid-induced oxidative stress causes looping disorders when exposure occurs during a specific developmental window. This highlights the importance of temporal control in negative regulation of heart looping.
Key Genes Involved in GO:1901208 negative regulation of heart looping
The following genes and proteins have been implicated in the negative regulation of heart looping, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Pitx2 | Transcription factor regulating left-right asymmetry; differential isoforms modulate heart looping | Studied in chick embryos for isoform-specific functions in heart looping |
| Sox18 | Transcription factor involved in heart development | Mechanistic studies suggest a role in heart development, potentially including looping |
| Nkx2-5 | Cardiac transcription factor essential for heart tube formation | May interact with negative regulators of looping; not directly cited in provided references |
| Tbx5 | Transcription factor required for heart development and chamber specification | Potential modulator of looping; not directly cited in provided references |
| Mef2c | Transcription factor involved in cardiac morphogenesis | May influence looping; not directly cited in provided references |
| Hand2 | Basic helix-loop-helix transcription factor critical for heart looping | Its regulation may be subject to negative control; not directly cited in provided references |
| Gata4 | Zinc finger transcription factor essential for heart development | Potential target of negative regulatory pathways; not directly cited in provided references |
| Nodal | TGF-beta family ligand involved in left-right asymmetry | Upstream of Pitx2; its negative regulation could affect looping; not directly cited in provided references |
| Lefty1/2 | Inhibitors of Nodal signaling | Negative regulators of left-right asymmetry that may impact heart looping; not directly cited in provided references |
| Bmp4 | Signaling molecule in heart development | May be modulated by negative regulators; not directly cited in provided references |
| Fgf8 | Fibroblast growth factor involved in cardiac morphogenesis | Potential role in looping regulation; not directly cited in provided references |
| Wnt11 | Non-canonical Wnt ligand implicated in cardiac looping | May be subject to negative regulation; not directly cited in provided references |
| Shh | Sonic hedgehog signaling in left-right asymmetry | Indirectly affects heart looping; not directly cited in provided references |
| Dnah5 | Dynein motor protein involved in ciliary function and left-right asymmetry | Mutations cause situs inversus; not directly cited in provided references |
| Zic3 | Zinc finger transcription factor in left-right patterning | Associated with heterotaxy; not directly cited in provided references |
| Acvr2b | Activin receptor in left-right signaling | May influence looping; not directly cited in provided references |
| Pkd2 | Polycystin-2, calcium channel in left-right axis determination | Mutations linked to laterality defects; not directly cited in provided references |
How Is negative regulation of heart looping Regulated?
The negative regulation of heart looping is itself controlled by upstream signaling pathways and environmental factors. Oxidative stress, for instance, can activate stress-responsive pathways that inhibit looping, as shown by isoniazid-induced heart looping disorders in zebrafish. Transcription factors such as Pitx2 are regulated at the level of alternative splicing, producing isoforms with distinct functions that may differentially repress looping. Additionally, Sox18 may act within a network of transcription factors that fine-tune heart development. The interplay between pro-looping and anti-looping signals ensures the precise morphogenesis of the heart.
negative regulation of heart looping and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Pitx2 | Laterality defects, congenital heart disease | Chick embryo with isoform-specific knockdown or overexpression |
| Sox18 | Heart developmental defects | Zebrafish or mouse knockout models |
| Nkx2-5 | Congenital heart defects | Mouse knockout and knock-in models |
| Tbx5 | Holt-Oram syndrome | Zebrafish and mouse models |
| Dnah5 | Primary ciliary dyskinesia with situs inversus | Zebrafish morpholino knockdown |
Congenital heart defects
Disruption of negative regulation of heart looping can lead to congenital heart defects, including malformations of the chambers and outflow tract. Studies in zebrafish show that isoniazid exposure causes heart looping disorders, providing a model for environmentally induced congenital heart disease. Similarly, aberrant expression of Pitx2 isoforms in the chick affects heart looping, linking molecular regulators to structural heart anomalies.
Laterality disorders
Negative regulation of heart looping is intimately tied to left-right asymmetry. Pitx2 is a key determinant of left-right asymmetry, and its differential isoform expression regulates heart looping direction. Perturbations in this regulation can result in situs inversus or heterotaxy, where organ positioning is randomized or abnormal.
Teratogen-induced embryopathies
Environmental teratogens such as isoniazid can negatively regulate heart looping through oxidative stress, leading to developmental defects. This highlights the importance of understanding negative regulatory mechanisms to assess teratogenic risks and develop protective strategies.
From negative regulation of heart looping-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate heart looping? | CRISPR knockout in zebrafish or mouse |
| What is the effect of a specific point mutation in gene Y on heart looping? | CRISPR point mutation knock-in in zebrafish |
| How does overexpression of gene Z affect looping? | Transgenic overexpression in chick or zebrafish |
| Where is protein X localized during heart looping? | Tagged knock-in (e.g., GFP) in mouse |
| What are the transcriptomic changes during negative regulation? | RNA-seq of microdissected heart tubes |
| Can a drug induce negative regulation of heart looping? | Zebrafish embryo treated with compounds like isoniazid |
How to Study the negative regulation of heart looping Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Identify negative regulators of heart looping |
| CRISPR knock-in | Precise mutation or tag insertion | Study point mutations or protein localization |
| RNA-seq | Transcriptome changes | Discover pathways involved in negative regulation |
| Live imaging | Morphogenetic movements | Visualize heart looping in real time |
| Immunohistochemistry | Protein localization | Detect Pitx2 or Sox18 in developing heart |
| Pharmacological treatment | Chemical effects on looping | Test teratogens like isoniazid |
| In situ hybridization | mRNA expression patterns | Map gene expression during looping |
| ChIP-seq | Transcription factor binding sites | Identify targets of Pitx2 or Sox18 |
CRISPR-based genetic screens
CRISPR knockout and knock-in screens in zebrafish or mouse can identify genes that negatively regulate heart looping. For example, knocking out candidate genes like Pitx2 or Sox18 can reveal their roles in looping [4,5].
Live imaging of heart looping
Time-lapse microscopy of fluorescently labeled hearts in zebrafish or chick embryos allows real-time visualization of looping dynamics and the effects of negative regulators.
Transcriptomic profiling
RNA-seq of hearts at different looping stages can identify genes and pathways involved in negative regulation, such as those induced by oxidative stress.
Pharmacological intervention
Treating embryos with compounds like isoniazid can induce negative regulation of heart looping, providing a chemical biology approach to study the process.
How CRISPR Can Be Used to Study GO:1901208 negative regulation of heart looping
Knockout
CRISPR knockout of candidate genes such as Pitx2 or Sox18 in zebrafish or mouse models can determine whether they are required for negative regulation of heart looping. Loss-of-function studies can reveal looping defects, as seen with Pitx2 isoform knockdown in chick.
Point Mutation
Introducing specific point mutations via CRISPR can mimic human variants associated with congenital heart defects. For example, mutations in Pitx2 or Sox18 can be modeled to study their impact on heart looping [4,5].
Knock-in
Knock-in of reporter tags (e.g., GFP) or conditional alleles allows visualization and temporal control of genes involved in negative regulation. This is useful for tracking Pitx2 expression during looping.
Overexpression
CRISPR activation or transgenic overexpression can test whether increased levels of a gene product enhance negative regulation of heart looping. Overexpression of Pitx2 isoforms in chick embryos can alter looping direction.
How EDITGENE Supports negative regulation of heart looping Research
Researchers studying negative regulation of heart looping-related genes often need to determine whether a candidate gene is causally involved in this process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies, from knockout to precise point mutations and overexpression, tailored to cardiac developmental models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of heart looping research.
Frequently Asked Questions About negative regulation of heart looping
What is negative regulation of heart looping?
Negative regulation of heart looping (GO:1901208) is any process that stops, prevents, or reduces the frequency, rate, or extent of heart looping, the asymmetric bending of the embryonic heart tube.
What genes are involved in negative regulation of heart looping?
Key genes include Pitx2, which has differential isoforms that regulate heart looping, and Sox18, a transcription factor implicated in heart development.
How does isoniazid affect heart looping?
Isoniazid causes heart looping disorder in zebrafish embryos by inducing oxidative stress, which acts as a negative regulator of looping.
What is the role of Pitx2 in heart looping?
Pitx2 is a transcription factor that regulates left-right asymmetry; its differential isoforms in the chick modulate heart looping direction and extent.
Which model organisms are used to study negative regulation of heart looping?
Zebrafish, chick, and mouse embryos are commonly used, as they allow visualization and genetic manipulation of heart looping [2,5].
What diseases are associated with defective negative regulation of heart looping?
Congenital heart defects and laterality disorders such as situs inversus can result from disruptions in negative regulation of heart looping [2,5].
How can CRISPR be used to study negative regulation of heart looping?
CRISPR knockout, knock-in, and overexpression can test the function of candidate genes like Pitx2 or Sox18 in heart looping [4,5].
What methods measure heart looping in embryos?
Live imaging, in situ hybridization, and immunohistochemistry are used to visualize looping and gene expression [2,5].
Is oxidative stress a negative regulator of heart looping?
Yes, oxidative stress induced by isoniazid leads to heart looping disorders in zebrafish, indicating a negative regulatory role.
What GO term describes inhibition of heart looping?
The Gene Ontology term GO:1901208 (negative regulation of heart looping) precisely describes this process.
Conclusion
Negative regulation of heart looping (GO:1901208) is a vital biological process that ensures proper cardiac morphogenesis by restraining the extent and timing of heart tube bending. Key regulators such as Pitx2 and environmental factors like oxidative stress have been identified, linking this process to congenital heart defects and laterality disorders [2,5]. Continued research using CRISPR-based models and advanced imaging will further unravel the molecular mechanisms and provide targets for therapeutic intervention.
References
- 2. Ni J et al.. 2020. Isoniazid causes heart looping disorder in zebrafish embryos by the induction of oxidative stress.. BMC Pharmacol Toxicol 21(1):22 PMID: 32178728
- 4. Liang J et al.. 2024. Mechanistic study of transcription factor Sox18 during heart development.. Gen Comp Endocrinol 350:114472 PMID: 38373462
- 5. Yu X et al.. 2001. Differential expression and functional analysis of Pitx2 isoforms in regulation of heart looping in the chick.. Development 128(6):1005-13 PMID: 11222154
